MedTrace Logo

A Clinical Trial of KT07 Capsule in the U.S.A

NCT02867358 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 391

Last updated 2020-08-31

No results posted yet for this study

Summary

The purpose of this study is to investigate clinical efficacy of KT07 capsule in alleviation of fever and other symptoms including nasal congestion, sore throat, cough, aches and pains, fatigue, headache, chills or sweats in subjects with acute uncomplicated influenza.

Conditions

  • Influenza, Human

Interventions

DRUG

KT07 Capsule

OTHER

Placebo

Sponsors & Collaborators

  • Yiling Pharmaceutical Inc.

    lead INDUSTRY

Principal Investigators

  • Xuedong Gao, MD · Yiling Pharmaceutical Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2020-07-31
Completion
2020-07-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02867358 on ClinicalTrials.gov